United Biomedical Competitors and Similar CompaniesClear all

United Biomedical's competitors and similar companies include AustinPx, Kamada Pharmaceuticals, Sosei Heptares and Camurus.

	United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.	AustinPx AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble drug molecules.	Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.	Sosei Heptares Sosei Heptares is a biopharmaceutical company that specializes in drug development.	Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
Founding Date	Founding Date 1985	Founding Date 2007	Founding Date 1990	Founding Date 1990	Founding Date 1991
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Hauppauge, US HQ Lanzhou, CN Yangzhou Shi, CN see more	Locations Georgetown, US HQ	Locations Rehovot, IL HQ Beit Kama, IL	Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB	Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB
Employees	Employees 44	Employees 622% decrease	Employees 380	Employees 37083% increase	Employees 2043% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 267.3 m	Valuation ($) 819.2 m	Valuation ($) 2.5 b
Employee Rating	Employee Rating 2.7	Employee Rating 5	Employee Rating 3.5	Employee Rating 3.9	Employee Rating 5
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $129.3m (FY, 2022)	Revenue (est.) ¥15.6b (FY, 2022)	Revenue (est.) kr956.3m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $59.1m (FY, 2022)	Cost of goods ¥490m (FY, 2022)	Cost of goods kr90.2m (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $70.2m (FY, 2022)	Gross profit ¥15.7b (FY, 2022)	Gross profit kr866.9m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income ($2.3m) (FY, 2022)	Net income ¥1.8b (FY, 2022)	Net income kr55.6m (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 52.7m	Total funding raised $ 90m	Total funding raised $ 65m	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

AustinPx

Georgetown, US

Employees

62↓ 2% decrease

AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble drug molecules.

View company

Kamada Pharmaceuticals

Rehovot, IL

Employees

380

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company

Sosei Heptares

Tokyo, JP

Employees

370

Sosei Heptares is a biopharmaceutical company that specializes in drug development.